Things to consider. Labs with kiestra would never consider adding an APAS module as they would not be compatible in the workflow. Kiestra is already a TOTAL lab solution. Labs with the scale to justify a kiestra system need to be very large. This equipment is custom designed per lab. Also outlay is in the millions. APAS will target small to medium labs and should be much cheaper to purchase.
Still shame tech wont be added bd lineup. Although if its superior and fda approved its not too late for a new deal.
Why the hype?, page-86
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
